BioAge Labs (BIOA) Competitors $4.93 +0.13 (+2.71%) As of 08/29/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock BIOA vs. SIGA, BCAX, VIR, RLAY, KROS, MGTX, TYRA, MRVI, ORGO, and RZLTShould you be buying BioAge Labs stock or one of its competitors? The main competitors of BioAge Labs include Siga Technologies (SIGA), Bicara Therapeutics (BCAX), Vir Biotechnology (VIR), Relay Therapeutics (RLAY), Keros Therapeutics (KROS), MeiraGTx (MGTX), Tyra Biosciences (TYRA), Maravai LifeSciences (MRVI), Organogenesis (ORGO), and Rezolute (RZLT). These companies are all part of the "pharmaceutical products" industry. BioAge Labs vs. Its Competitors Siga Technologies Bicara Therapeutics Vir Biotechnology Relay Therapeutics Keros Therapeutics MeiraGTx Tyra Biosciences Maravai LifeSciences Organogenesis Rezolute Siga Technologies (NASDAQ:SIGA) and BioAge Labs (NASDAQ:BIOA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment. Do insiders and institutionals have more ownership in SIGA or BIOA? 55.4% of Siga Technologies shares are owned by institutional investors. 2.0% of Siga Technologies shares are owned by company insiders. Comparatively, 20.8% of BioAge Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is SIGA or BIOA more profitable? Siga Technologies has a net margin of 45.73% compared to BioAge Labs' net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat BioAge Labs' return on equity.Company Net Margins Return on Equity Return on Assets Siga Technologies45.73% 40.52% 35.62% BioAge Labs N/A -25.39%-23.22% Which has higher earnings & valuation, SIGA or BIOA? Siga Technologies has higher revenue and earnings than BioAge Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiga Technologies$138.72M4.33$59.21M$1.137.42BioAge LabsN/AN/A-$71.11MN/AN/A Does the media prefer SIGA or BIOA? In the previous week, Siga Technologies had 3 more articles in the media than BioAge Labs. MarketBeat recorded 4 mentions for Siga Technologies and 1 mentions for BioAge Labs. BioAge Labs' average media sentiment score of 1.87 beat Siga Technologies' score of 1.34 indicating that BioAge Labs is being referred to more favorably in the news media. Company Overall Sentiment Siga Technologies Positive BioAge Labs Very Positive SummarySiga Technologies beats BioAge Labs on 7 of the 9 factors compared between the two stocks. Get BioAge Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOA vs. The Competition Export to ExcelMetricBioAge LabsPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$176.74M$828.76M$2.54B$9.78BDividend YieldN/A4.84%2.54%4.03%P/E RatioN/A1.1026.4726.59Price / SalesN/A26.57112.33111.53Price / CashN/A19.5623.5159.26Price / Book0.606.5532.226.58Net Income-$71.11M-$5.07M$25.55M$265.95M7 Day Performance6.94%0.71%0.46%0.17%1 Month Performance12.05%5.87%2.82%3.90%1 Year PerformanceN/A19.64%26.01%19.67% BioAge Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOABioAge LabsN/A$4.93+2.7%N/AN/A$176.74MN/A0.00N/ASIGASiga Technologies2.4135 of 5 stars$9.13+4.3%N/A-7.1%$653.76M$138.72M8.0840News CoverageBCAXBicara Therapeutics1.8977 of 5 stars$11.84+1.8%$32.25+172.4%N/A$646.03MN/A-3.7432VIRVir Biotechnology3.3273 of 5 stars$4.58+4.6%$30.25+560.5%-40.2%$636.24M$74.21M-1.15580News CoveragePositive NewsAnalyst UpgradeRLAYRelay Therapeutics2.2382 of 5 stars$3.69+8.2%$17.25+367.5%-47.1%$636.20M$10.01M-1.89330Trending NewsAnalyst ForecastAnalyst RevisionKROSKeros Therapeutics3.3766 of 5 stars$15.56+2.6%$30.00+92.8%-66.5%$631.97M$3.55M50.20100News CoverageMGTXMeiraGTx4.5628 of 5 stars$7.83-0.3%$24.00+206.5%+79.4%$629.90M$33.28M-3.84300News CoveragePositive NewsTYRATyra Biosciences2.1159 of 5 stars$11.71+0.1%$30.83+163.3%-44.3%$624.11MN/A-6.5820MRVIMaravai LifeSciences4.0272 of 5 stars$2.45+2.5%$5.75+134.7%-73.3%$623.92M$259.18M-1.80610Positive NewsORGOOrganogenesis4.2324 of 5 stars$4.89+9.4%$7.50+53.4%+78.8%$620.34M$482.04M-34.93950News CoveragePositive NewsRZLTRezolute3.4329 of 5 stars$7.00+0.6%$12.20+74.3%+49.6%$608.97MN/A-6.0940News CoveragePositive News Related Companies and Tools Related Companies SIGA Alternatives BCAX Alternatives VIR Alternatives RLAY Alternatives KROS Alternatives MGTX Alternatives TYRA Alternatives MRVI Alternatives ORGO Alternatives RZLT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOA) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAge Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAge Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
